Publication | Open Access
Efficacy And Safety Of Bradykinin B2 Receptor Inhibition With Oral PHVS416 In Treating Hereditary Angioedema Attacks: Results Of RAPIDe-1 Phase 2 Trial
14
Citations
0
References
2023
Year
Cardiovascular DiseaseVascular PharmacologyPharmacologyOral Phvs416Vascular BiologyPharmacotherapyRapide-1 Phase 2MedicineNovel Therapy
No additional data available for this publication yet. Check back later!